ICU issues in Haem Malignancy cont… Flashcards
(9 cards)
FEBRILE NEUTROPENIA
Q. Definition
Q. Causes of fever in neutropenia
Q.Invx
Q.Management
Q.Choice of Antimicrobials
Q.Role of GCSF
Definitions:
* Neutropenia: ANC < 1.5 × 10⁹/L * Severe Neutropenia: ANC < 0.5 × 10⁹/L
- Fever in neutropenia can be non-infectious (e.g. malignancy, chemotherapy, DVT) or infectious.
- Distinguishing infection from non-infectious causes is very difficult.
- Prompt identification of infectious source is critical:
1.# Investigate body fluids – urine, blood, sputum, pleural/ascitic/tissue fluid
* Blood cultures x2 sets
* Important labs: WCC, CRP, Procalcitonin
*Relevant Imaging-USG for suspected cholecystitis/CT scan
* Neutropenic sepsis has high mortality – initiate empiric antibiotics early.
2.# First-line treatment:
* Anti-pseudomonal beta-lactam with a good Gram positive and Gram negative cover (e.g. cefepime, tazobactam-piperacillin)
* Add aminoglycoside/fluoroquinolone if AB resistance is suspected or for septic shock
*Add vanc if suspicion of MRSA or resistant Enterococcus/risk factors/ previous colonisation
* Cover suspected pneumonias or CLABSI with suitable agents
* Empirical antifungals if high suspicion or persistent fever with no source found
⸻
3.#G-CSF (e.g. filgrastim):
* Used to promote neutrophil recovery
* Particularly for profound neutropenia (ANC < 0.5 × 10⁹/L)
* SE:
-Flu like symptoms
-Rash
-Bone pain
4.Environmental measures: * Hand hygiene * Barrier precautions * Protective isolation in high-risk patients
Neutropenic enterocolitis
Q.Pathophysiology
Q. Diagnosis
Q.Complications
Q.Management
Classic triad:
- Fever - Abdominal pain -Diarrhoea * Common post-chemotherapy
*Pathophysiology:
1.Chemotherapy-induced colonic mucosal wall damage
2. Thrombocytopenia → GI bleeding 3. Translocation of gut flora & pathogenic bacteria
* Bacteraemia * GI bleeding * Colonic perforation
* CT: -Bowel wall thickening, pneumatosis- (colonic pneumatosis suggests necrosis) -Free Gas- sugg perforation
* Bowel rest * Parenteral nutrition (PN) * Broad-spectrum antibiotics (cover Gram-negative, anaerobes) * Surgery if: bowel perforation, life-threatening GI bleed, immunological compromise, or sepsis
Respiratory Failure in Haematological Malignancies
Q. Causes of RF in Haem malignancy
Q. Causes specific to HCT
Q. Outline Mx
Causes of Acute Respiratory Failure (ARF):
=>Non-Infectious:
1. * ARDS
2* Drug-induced pneumonitis
3* Radiation pneumonitis
4* Pulmonary oedema
5* Pulmonary fibrosis
6* Tumour-related obstruction
7 Pulmonary Embolism
8 Complications of HCT:
- GVHD
- DAH (diffuse alveolar haemorrhage)
- Idiopathic pneumonia syndrome
- Engraftment syndrome
=> Infectious:
* Bacterial: Staph, Strep, Pseudomonas, Klebsiella, Enterococcus, Nocardia, Mycoplasma, Legionella
* Viral: CMV, HSV, VZV, RSV, adenovirus, influenza, parainfluenza
* Fungal: Aspergillus, Candida, PCP
* Others: Mycobacterium tuberculosis
* Early use of NHF (nasal high flow) and NIV (non-invasive ventilation) * Lung-protective ventilation if intubated * Full ventilation = poor prognostic indicator * BAL (bronchoalveolar lavage) – useful in select patients but may precipitate ARF * Trend: * Prognosis has improved, but intubation still carries high mortality
AKI
Q. Causes of AKI in haem malignancy
Causes include:
- Sepsis
2* Monoclonal light chain deposition (e.g., multiple myeloma)
3* Tumor lysis syndrome
4* Chemotherapy-induced toxicity (e.g., methotrexate, foscarnet)
5* Antibiotic toxicity (e.g., aminoglycosides, amphotericin)
6* Hepatorenal syndrome (HRS, secondary to VOD)
#Need for RRT is an independent predictor of mortality
Q. Causes of Neurological dysfunction in Haem Malignancy
- cerebral infarcts,
- CVST*
- hyperviscosity syndrome*
- chemotherapy-induced encephalopathy (e.g., high-dose cytarabine, Ifosfamide toxicity)
- Septic encephalopathy
- Metabolic causes
- Meningoencephalitis
Q.Causes of Gastrointestinal & Liver Dysfunction in Hematologic Malignancies
1* GvHD
2* Infections: EBV, CMV, hepatitis
3* Tumor infiltration
4* VOD
5* Drugs (e.g., methotrexate, platinum agents)
- Tumor lysis syndrome:
Q. Pathophysiology and general outline
- Rapid tumor cell death releases large amounts of intracellular contents (↑ K+, PO4, urate)
- Leads to: AKI, metabolic disturbances
- Common in high-grade lymphomas (e.g., Burkitt’s), acute leukemias
- Management: Aggressive IV hydration, correct electrolyte/acid-base imbalance, allopurinol, rasburicase,+/- dialysis
Q* Poor prognostic indicators
- Advanced age
- Allogeneic transplant
- Mechanical ventilation
- Vasopressor use
- GvHD
- Elevated serum lactate at admission
What are some strategies to improve outcomes in pts with haem malignancy
Early multidisciplinary care: hematologists, intensivists, ID
# Strict infection control & hygiene measures
# Early ICU involvement